Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Two more universities set to join IUCRC BRAIN at University of Houston to advance neurotechnology

Two more universities, West Virginia University (WVU) and Georgia Institute of Technology, have been funded by the National Science Foundation and are set to join the Industry-University Cooperative Research Center for Building Reliable Advances and Innovations in Neurotechnology (IUCRC BRAIN), housed at the University of Houston.

23 Aug 2023

Catheter ablation linked to lower risk of dementia in all patients with atrial fibrillation

Previous studies have shown a link between catheter ablation and a lower risk of dementia and premature death for patients with atrial fibrillation.

23 Aug 2023

Sedentary lifestyle in young people may harm heart health

Hours of inactivity during childhood could be setting the stage for heart attacks and strokes later in life, according to research presented at ESC Congress 2023.

23 Aug 2023

Study: Nearly half of heart attack and stroke survivors don't know their LDL cholesterol levels

A 2023 survey from the American Heart Association conducted by The Harris Poll, found that a majority (70%) of heart attack and stroke survivors are unaware that LDL cholesterol is commonly referred to as 'bad cholesterol.'

23 Aug 2023

Aspirin underutilized for preventing heart attack, stroke

For people who have experienced a heart attack or stroke, taking a daily aspirin has been shown to help prevent a second one.

22 Aug 2023

Texas Heart Institute receives $1.14 million grant to develop first-in-class drug to treat cardiovascular disease

The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute (THI) a two-year, $1.14 million grant to develop a novel, first-in-class drug to treat cardiovascular disease (CVD) as a significant improvement to current treatment regimens - specifically for adverse events arising from atherosclerosis.

22 Aug 2023

Prolonged pain after myocardial infarctions associated with increase in risk of all-cause mortality

Researchers examined the association between different severity levels of pain a year after myocardial infarction and the risk of all-cause mortality.

22 Aug 2023

Keeping fit may help prevent atrial fibrillation and stroke

A study in more than 15,000 people has found that physical fitness is linked with a lower likelihood of developing atrial fibrillation and stroke. The research is presented at ESC Congress 2023.

22 Aug 2023

Aspirin adherence after heart attack linked to lower risk of recurrent heart attack, stroke, death

Heart attack patients who do not take daily aspirin have an elevated likelihood of recurrent myocardial infarction, stroke or death compared with those who consistently take the drug, according to research presented at ESC Congress 2023.

22 Aug 2023

Time-restricted feeding may correct the circadian disruptions in Alzheimer's disease

One of the hallmarks of Alzheimer's disease is disruption to the body's circadian rhythm, the internal biological clock that regulates many of our physiological processes.

21 Aug 2023

New AI-based screening strategy uses ECG to detect heart defects

Researchers explore the use of artificial intelligence in enhancing the yield of conventional screening for ASDs using 12-lead electrocardiography.

21 Aug 2023

Is there an association between sleep-disordered breathing and Alzheimer's disease?

Researchers evaluated the impact of sleep-disordered breathing (SDB) on neuroimaging biomarkers of Alzheimer's disease (AD).

21 Aug 2023

Unleashing the Power of Microfluidic Picodroplets

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Richard Hammond, Chief Technical Officer at Sphere Bio, about their microfluidic picodroplet technology and more.

From Fluidic Sciences and Sphere Bio 21 Aug 2023

Exploring developmental pathways and disease interactions in nervous and stomatognathic systems

Scientists discuss the intricate relationship between the nervous and stomatognathic systems.

21 Aug 2023

E-cigarette usage nudges people toward quitting smoking, study shows

E-cigarettes do have value as a smoking cessation aid, according to a new study just released by a team of MUSC Hollings Cancer Center researchers.

18 Aug 2023

Phase I trial shows promise: Brain stimulation spurs upper-extremity recovery in stroke patients

Researchers performed an open-label phase I trial.

18 Aug 2023

Predicting risk of cardiovascular events with Life's Essential 8 scores

Researchers determine the relationship between LE8 scores and cardiovascular disease, subtype CVD events, and all-cause mortality.

18 Aug 2023

Medications for chronic diseases can impair thermoregulation, especially in hot weather

Medications to treat various chronic diseases may hinder the body’s ability to lose heat and regulate its core temperature to optimal levels.

17 Aug 2023

AI model can detect atrial septal defect in ECGs with high accuracy

The AI model was more efficient at detecting signatures of atrial septal defect (ASD) in electrocardiograms (ECG) than traditional methods.

17 Aug 2023

New study offers preliminary estimates of mortality risk by stage in Alzheimer's disease

Researchers examine the expected survival of people at each stage of Alzheimer's disease.

17 Aug 2023

Stroke News and Research

Further Reading

Two more universities set to join IUCRC BRAIN at University of Houston to advance neurotechnology

Catheter ablation linked to lower risk of dementia in all patients with atrial fibrillation

Sedentary lifestyle in young people may harm heart health

Study: Nearly half of heart attack and stroke survivors don't know their LDL cholesterol levels

Aspirin underutilized for preventing heart attack, stroke

Texas Heart Institute receives $1.14 million grant to develop first-in-class drug to treat cardiovascular disease

Prolonged pain after myocardial infarctions associated with increase in risk of all-cause mortality

Keeping fit may help prevent atrial fibrillation and stroke

Aspirin adherence after heart attack linked to lower risk of recurrent heart attack, stroke, death

Time-restricted feeding may correct the circadian disruptions in Alzheimer's disease

New AI-based screening strategy uses ECG to detect heart defects

Is there an association between sleep-disordered breathing and Alzheimer's disease?

Unleashing the Power of Microfluidic Picodroplets

Exploring developmental pathways and disease interactions in nervous and stomatognathic systems

E-cigarette usage nudges people toward quitting smoking, study shows

Phase I trial shows promise: Brain stimulation spurs upper-extremity recovery in stroke patients

Predicting risk of cardiovascular events with Life's Essential 8 scores

Medications for chronic diseases can impair thermoregulation, especially in hot weather

AI model can detect atrial septal defect in ECGs with high accuracy

New study offers preliminary estimates of mortality risk by stage in Alzheimer's disease

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News